You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 127 No. 10, October 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Complement Activation and Polymorphonuclear Neutrophil Leukocyte Elastase in Sepsis

Correlation With Severity of Disease

Marco Gardinali, MD; Pietro Padalino, MD; Sergio Vesconi, MD; Anna Calcagno, MD; Salvatore Ciappellano; Luisa Conciato, MD; Osvaldo Chiara, MD; Angelo Agostoni, MD; Angelo Nespoli, MD

Arch Surg. 1992;127(10):1219-1224.


Abstract

• Complement activation is necessary for an adequate immune and inflammatory response to infections. Activation releases anaphylatoxins that cause vasodilation, increase vascular permeability, and trigger release of polymorphonuclear neutrophil leukocyte (PMN) lysosomal enzyme and oxygen radicals. Under normal circumstances, an orderly progression of such events has a beneficial antimicrobial effect. The same mechanism, however, when uncontrolled, may damage host tissues. To provide information about the clinical importance of such events in sepsis, different complement parameters (C3, C4, and the desarginated forms of C3a [C3ades-Arg] and C5a [C5ades-Arg]), PMN elastase, and malondialdehyde (a by-product of membrane peroxidation by oxygen radicals) were measured daily in 26 septic patients and correlated with two objectively assessed and previously validated severity scores (acute physiology and chronic health evaluation [APACHE II] and Sepsis Severity Score [SSS]). Nonsurvivors (n=12) had significantly greater and longer lasting complement activation than that in survivors, as reflected by higher levels of catabolic peptides (C3ades-Arg) and lower levels of native proteins (C3 and C4). C3ades-Arg, C3, C4, and the C3ades-Arg-C3 ratio were correlated with Sepsis Severity Scores. Polymorphonuclear neutrophil leukocyte elastase levels were higher in nonsurvivors and were correlated with C3ades-Arg and the C3ades-Arg-C3 ratio. Malondialdehyde levels were significantly higher in all patients than in controls, without, however, any relationship to severity of disease or clinical outcome. Since the higher and more persistent the complement activation and polymorphonuclear neutrophil leukocyte stimulation, the worse the patient's prognosis, we conclude that these mechanisms may be important in the clinical development of sepsis.

(Arch Surg. 1992;127:1219-1224)



Author Affiliations

From the Institute of Emergency Surgery (Drs Padalino, Chiara, and Nespoli), the Clinical Medicine (Drs Gardinali, Calcagno, Conciato, and Agostoni), Intensive Care Unit San Paolo Hospital (Dr Vesconi), and the Department of Food Science and Microbiology (Mr Ciappellano), University of Milan (Italy).


Footnotes

Accepted for publication November 9, 1991.

Reprint requests to Istituto de Chirurgia d'Urgenza, Università di Milano, Ospedale Policlinico IRCCS, via F Sforza 35-20122 Milano, Italia (Dr Padalino).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Administration of C1 Inhibitor Reduces Neutrophil Activation in Patients with Sepsis
Zeerleder et al.
CVI 2003;10:529-535.
ABSTRACT | FULL TEXT  

Inhibition of Activation of the Classical Pathway of Complement by Human Neutrophil Defensins
van den Berg et al.
Blood 1998;92:3898-3903.
ABSTRACT | FULL TEXT  

Therapeutic Inhibition of the Complement System
Makrides
Pharmacol. Rev. 1998;50:59-88.
ABSTRACT | FULL TEXT  

Arginine 206 of the C5a Receptor Is Critical for Ligand Recognition and Receptor Activation by C-terminal Hexapeptide Analogs
DeMartino et al.
J. Biol. Chem. 1995;270:15966-15969.
ABSTRACT | FULL TEXT  

Enhanced Release of Elastase Is Not Concomitant With Increased Secretion of Granulocyte-Activating Cytokines in Whole Blood From Patients With Sepsis
Ertel et al.
Arch Surg 1994;129:90-98.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.